Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07077122Recruiting
Randomised, single-blind trial (5 arms), sponsored by National and Kapodistrian University of Athens. Primary endpoint: high-sensitivity C-reactive protein. Started Aug 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07077122.